SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
443.00    10.00 (2.31%)
Bid:
440.00
Ask:
443.00
Spread: 3.00 (0.682%)
Market Cap: £218.72m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

Trading Update

14 Jan 2020 07:00

RNS Number : 6507Z
City of London Investment Group PLC
14 January 2020
 

 

City of London Investment Group PLC

14 January 2020



CITY OF LONDON INVESTMENT GROUP PLC

("City of London", "the Group" or "the Company")

 

FUNDS UNDER MANAGEMENT AS AT 31 December 2019,

TRADING UPDATE

 

City of London (LSE: CLIG), a leading specialist asset management group offering a range of institutional products investing in closed-end funds, announces that as at 31 December 2019, FuM were US$6 billion (£4.5 billion). This compares with US$5.4 billion (£4.3 billion) at the Company's year-end on 30 June 2019. A breakdown by strategy follows:

 

 

FuM ($mn)

 

 

 

Strategy Index

 

 

 

 

 

 

 

 

 

 

 

 

 

Dec-19

Jun-19

%

 

Net

 

 

 

%

 

(estimate)

inc/dec

 

Flows

 

 

 

inc/dec

EM

4,429

4,221

5%

 

(118)

 

MSCI EM

 

7%

DEV

1,109

729

52%

 

272

 

MSCI ACWI

 

7%

Opportunistic Value

270

233

16%

 

20

 

ACWI/Barclays Global Agg

 

5%

Frontier

206

206

0%

 

8

 

S&P Frontier 150

 

0%

 

6,014

5,389

 

 

182

 

 

 

 

 Excludes seed investments

 

The EM and International Developed strategies outperformed, driven by narrower discounts, positive country allocation and good NAV performance. The Opportunistic Value Strategy outperformed led by good NAV performance and significant discount narrowing. The Frontier strategy underperformed due primarily to negative country allocation and discount widening.

 

During the period under review, the Developed strategies recorded net inflows of $272 million. The EM strategies saw net outflows of $118 million. We have to date received notification of circa $200 million of net inflows in aggregate across all strategies, which we expect to fund over the next quarter.

 

With regard to business development, the Group continues to maintain an active pipeline across all of its major CEF offerings with an increased interest in the diversification CEF strategies. 

 

Operations

 

The Group's income currently accrues at a weighted average rate of approximately 75 basis points of FuM, net of third party commissions. "Fixed" costs are c£1.1 million per month, and accordingly the current run-rate for operating profit, before profit-share of 30% and an EIP charge of 5%, is approximately £1.8 million per month based upon current FuM and a US$/£ exchange rate of US$1.3257 to £1 as at 31 December 2019.

 

The Group estimates the unaudited profit before taxation for the six months ended 31 December 2019 to be approximately £6.3 million, which compares with £5.2 million for the equivalent period to 31 December 2018.

 

The Company is currently in a close period which will end with the publication of results for the six months ended 31 December 2019 on 17 February 2020.

 

Dividend

 

In recognition of the improved results and having regard to the current dividend cover policy the Board has decided to increase the interim dividend by 1p to 10p per share, which will be paid on 20 March 2020 to shareholders registered at the close of business on 6 March 2020 (2019: 9 pence).

 

Template

 

Please see the attached graph which is based on the following assumptions and includes the estimated quarterly cost of the dividend:

 

http://www.rns-pdf.londonstockexchange.com/rns/6507Z_1-2020-1-13.pdf

 

Key assumptions:

 

(June 2019 comparatives in Italics)

 

-

Starting point Current FuM (end December 2019)

-

Net increase for the remainder of this financial year (straight-lined to June 2020):

- emerging market CEF strategy zero (zero)

- non-emerging market CEF strategies US$250 (US$250m over the full year)

-

Net increase in 2020/2021 (straight-lined to June 2021):

- emerging market CEF strategy zero

- non-emerging market CEF strategies US$250m

-

Operating margin adjusted monthly for change in product mix and commission run-off

-

Market growth: 0%

-

Overheads for 2019/20: no increase on 2018/2019 (0%)

-

Overheads for 2020/21: +3% compared with 2018/2019

-

EIP cost for 2019/20: 5% of operating profit (5%)

-

EIP cost for 2020/21: n/a now falls within 30% profit-share

-

Corporation tax based on an estimated average rate of 21% (21%)

-

Exchange rate assumed to be £1/$1.31 for entire period (£1/US$1.27)

-

Number of CLIG Shares in issue (26.6m) less those held by the ESOP Trust (1.7m) as at 31 December 2019 (26.6 m CLIG shares in issue less 1.5m ESOP Trust holding)

 

For further information, please visit http://www.citlon.co.uk/ or contact:

 

Tom Griffith, CEO

City of London Investment Group PLC

Tel: 001-610-380-0435

 

Martin Green

Zeus Capital Limited

Financial Adviser & Broker

Tel: +44 (0)20 3829 5000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFSFMDESSESF
Date   Source Headline
2nd Dec 201112:30 pmRNSResponse to Statement by City of London
1st Dec 20119:38 amRNSSupport for Capital Return Programme
1st Dec 20117:00 amRNSSupport for Capital Return Programme
2nd Nov 20112:19 pmRNSHolding(s) in Company
25th Oct 20114:39 pmRNSHolding(s) in Company
17th Oct 201112:57 pmRNSHolding(s) in Company - Replacement
11th Oct 201112:11 pmRNSTR1 Form
5th Oct 20111:27 pmRNSPDMR Transaction
4th Oct 20114:26 pmRNSResult of AGM
3rd Oct 20117:00 amRNSInterim Management Statement
8th Sep 20117:00 amRNSDirector/PDMR Shareholding
6th Sep 20117:00 amRNSFinal Results
22nd Aug 201112:52 pmRNSNotice of Results
20th Jul 201112:00 pmRNSHolding(s) in Company
4th Jul 201111:49 amRNSBlocklisting Interim Review
6th Jun 20112:57 pmRNSHolding(s) in Company
3rd Jun 20117:00 amRNSAppointment of Non-Executive Director
17th May 20115:12 pmRNSHolding(s) in Company
15th Apr 20112:25 pmRNSHolding(s) in Company
16th Mar 20119:07 amRNSDirector/PDMR Shareholding
8th Mar 201112:14 pmRNSHolding(s) in Company
7th Mar 20117:00 amRNSInterim Management Statement
15th Feb 20112:52 pmRNSHolding(s) in Company
14th Feb 20113:40 pmRNSDirector/PDMR Shareholding
3rd Feb 20119:22 amRNSDirector/PDMR Shareholding
31st Jan 20117:00 amRNSTotal Voting Rights
24th Jan 20112:58 pmRNSHolding(s) in Company
24th Jan 20117:00 amRNSHalf Yearly Report
4th Jan 20117:00 amRNSBlocklisting Interim Review
16th Dec 20104:01 pmRNSHolding(s) in Company
10th Dec 20103:44 pmRNSEndowment of Foundation by Executive Director
10th Dec 201011:01 amRNSLetter to Edinburgh Dragon
6th Dec 20107:00 amRNSFunds under Management & Trading Update
4th Nov 20104:32 pmRNSDirector/PDMR Shareholding
29th Oct 20108:10 amRNSCommencement of Trading on the Official List
26th Oct 20103:54 pmRNSPublication of Prospectus
26th Oct 20103:54 pmRNSPublication of Prospectus
25th Oct 20107:00 amRNSAGM Trading Update
25th Oct 20107:00 amRNSAGM Trading Update
19th Oct 201010:52 amRNSDirector/PDMR Shareholding
5th Oct 20104:57 pmRNSHolding(s) in Company
4th Oct 201010:43 amRNSHolding(s) in Company
1st Oct 20107:00 amRNSMove to the Official List and directors' dealings
16th Sep 20104:21 pmRNSDirector/PDMR Shareholding
16th Sep 20102:34 pmRNSHolding(s) in Company
15th Sep 20107:00 amRNSDirector/PDMR Shareholding
13th Sep 20107:00 amRNSFinal Results
25th Aug 20104:20 pmRNSHolding(s) in Company
23rd Aug 201011:37 amRNSDirectorate Change
11th Aug 201011:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.